No Data
No Data
No Data
No Data
No Data
We're Hopeful That Eliem Therapeutics (NASDAQ:ELYM) Will Use Its Cash Wisely
We can readily understand why investors are attracted to unprofitable companies. For example, although software-as-a-service business Salesforce.com lost money for years while it grew recurring reve
Simply Wall StApr 16 15:28 ET
SHAREHOLDER ALERT: Kaskela Law LLC Announces Investigation of Eliem Therapeutics, Inc. (ELYM) and Encourages Investors to Contact the Firm
PHILADELPHIA, April 15, 2024 /PRNewswire/ -- Kaskela Law LLC, announces that it is investigating Eliem Therapeutics, Inc. (NASDAQ: ELYM) ("Eliem") on behalf of the company's shareholders. The investi
PR NewswireApr 15 08:15 ET
HROW, HCAT and EGRX Are Among After Hour Movers
Seeking AlphaApr 12 17:05 ET
SHAREHOLDER ALERT: Rigrodsky Law, P.A. Is Investigating Eliem Therapeutics, Inc. Merger
Wilmington, Delaware--(Newsfile Corp. - April 12, 2024) - Rigrodsky Law, P.A. is investigating Eliem Therapeutics, Inc. ("Eliem") (NASDAQ: ELYM) regarding possible breaches of fiduciary duties and oth
newsfileApr 12 15:25 ET
12 Health Care Stocks Moving In Friday's Pre-Market Session
GainersPaxMedica (NASDAQ:PXMD) stock moved upwards by 104.2% to $0.84 during Friday's pre-market session. The market value of their outstanding shares is at $6.2 million. Allarity Therapeutics (NASDAQ
BenzingaApr 12 08:09 ET
GLYC, APLD and AUTL Are Among After Hour Movers
Seeking AlphaApr 11 17:00 ET
MindOverMatter : Sold SPRC at $2 watching
102415025 : Not right plunging
Stock_DriftOP MindOverMatter: Awesome!!
Stock_DriftOP 102415025: We don’t like it either.
MindOverMatter Stock_DriftOP: liked that gap fill on sprc
No Data
No Data